Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN952885 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Interleukin 28B (Interferon, lambda 3) (IL28B) (AA 33-63), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- Purified through a Protein A column followed by peptide affinity purification
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- N-Term, AA 33-63
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Impact of IL28B genotype on the early and sustained virologic response in treatment-naïve patients with chronic hepatitis C.
Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.
Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus.
Observed and calculated interleukin-28B genotype frequencies in hepatitis C virus infection.
Stättermayer AF, Stauber R, Hofer H, Rutter K, Beinhardt S, Scherzer TM, Zinober K, Datz C, Maieron A, Dulic-Lakovic E, Kessler HH, Steindl-Munda P, Strasser M, Krall C, Ferenci P
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011 Apr;9(4):344-350.e2
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011 Apr;9(4):344-350.e2
Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.
Grebely J, Petoumenos K, Hellard M, Matthews GV, Suppiah V, Applegate T, Yeung B, Marks P, Rawlinson W, Lloyd AR, Booth D, Kaldor JM, George J, Dore GJ, ATAHC Study Group.
Hepatology (Baltimore, Md.) 2010 Oct;52(4):1216-24
Hepatology (Baltimore, Md.) 2010 Oct;52(4):1216-24
Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus.
Pineda JA, Caruz A, Rivero A, Neukam K, Salas I, Camacho A, Palomares JC, Mira JA, Martínez A, Roldán C, de la Torre J, Macías J
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010 Oct 1;51(7):788-95
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010 Oct 1;51(7):788-95
Observed and calculated interleukin-28B genotype frequencies in hepatitis C virus infection.
Lindh M, Lagging M, Norkrans G, Hellstrand K
Hepatology (Baltimore, Md.) 2010 Nov;52(5):1860-1; author reply 1861-2
Hepatology (Baltimore, Md.) 2010 Nov;52(5):1860-1; author reply 1861-2
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
